Dendreon (DNDN) Moves Q411 Conference Call Time to 9am ET
- Wall Street propped up by tech, discretionary stocks
- Boston Scientific (BSX) to Acquire EndoChoice (GI) in ~$210M Deal
- Oil prices fall as hopes for a deal in Algiers fade
- Dollar gains against euro on Deutsche Bank fears, falls vs Mexican peso
- Pre-Open Stock Movers 09/27: (GI) (KITE) (INFI) Higher; (NAT) (SXL) (RICE) Lower (more...)
Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Monday, February 27, 2012, at 9:00 a.m. ET to review fourth quarter and year-end financial results. This conference call was previously scheduled at 4:30 p.m. ET on the same date.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WebMD Health (WBMD) Names Blake DeSimone CFO; Sees Q3, FY Results at High End of Guidance
- Nomura Securities Cuts Price Target on Carnival Corp. (CCL) to $59
- Goldman Sachs Thinks Lilly (LLY) is Compelling With or Without Potential Blockbuster AD Drug Sola; Analyst Raises Rating to 'Buy'
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!